Skip to main content
. 2015 Sep 10;36(11):1314–1326. doi: 10.1093/carcin/bgv128

Table 2.

Number of variants and regions included through each prioritization method

SCC AC SCLC
Variants Regions Variants Regions Variants Regions
Novel variants P = 10−6 to 10−3 15 11 8 7 3 3
P < 0.0001 first stage 123 75 93 62 92 68
P > 0.0001 but SFDR rank in top 100 26 20 21 19 17 14
P > 0.0001 but ABF rank in top 100 20 19 35 29 36 32
P > 0.0001 but HM rank in top 100 12 12 24 24 47 39

Region corresponds to an area of LD R2 > 0.8 or with 500 kbp.